Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 11 to 15, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 11 to 15, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Life Expectancy Reduced Considerably Due to COVID-19
FRIDAY, Jan. 15, 2021 (HealthDay News) — The COVID-19 pandemic has had a considerable impact on life expectancy in the United States, especially among Black and Latino populations, according to a study published online Jan. 13 in the Proceedings of the National Academy of Sciences.
Primary Care-Recorded Mental Illness Decreased During COVID-19
FRIDAY, Jan. 15, 2021 (HealthDay News) — In April 2020, there were reductions in primary care-recorded mental illness and self-harm in the United Kingdom, according to a study published online Jan. 11 in The Lancet Public Health.
Previous COVID-19 Infection May Confer Immunity for at Least Five Months
FRIDAY, Jan. 15, 2021 (HealthDay News) — Immunity against the new coronavirus can last for at least five months in most people who have been infected, British researchers report.
Referrals for Acute Heart Failure Dropped During COVID-19
FRIDAY, Jan. 15, 2021 (HealthDay News) — In the eight weeks following the first reported U.K. death due to COVID-19, there was a decrease in referral of patients with acute heart failure, with a corresponding significant increase in mortality, according to a study published online Jan. 6 in ESC Heart Failure.
Smokers More Likely to Report Symptoms Suggestive of COVID-19
FRIDAY, Jan. 15, 2021 (HealthDay News) — Current smokers are more likely to report symptoms suggesting a diagnosis of COVID-19, according to a study published online Jan. 6 in Thorax.
One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine
FRIDAY, Jan. 15, 2021 (HealthDay News) — Roughly one-third of Americans say they will decline a COVID-19 vaccine, according to research published online Jan. 4 in Social Science & Medicine.
Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS
FRIDAY, Jan. 15, 2021 (HealthDay News) — Researchers are exploring the potential immunomodulatory and anti-inflammatory effects of umbilical cord mesenchymal stem cell infusions for acute respiratory distress syndrome in COVID-19, according to a study published online Jan. 5 in Stem Cells Translational Medicine.
Incidence of COVID-19 Increased in Children Since September
THURSDAY, Jan. 14, 2021 (HealthDay News) — The incidence of laboratory-confirmed COVID-19 increased since September among children, adolescents, and young children, according to research published in the Jan. 13 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Mental Health Disorders Common Among ICU Staff During COVID-19
Significant Association ID"d Between Hepatitis C, Overactive Bladder
Study Looks at Barriers to Initiation of Rotavirus Vaccine
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older